Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009
- PMID: 25957578
- PMCID: PMC4494157
- DOI: 10.1186/s12885-015-1413-8
Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009
Erratum in
-
Correction to: Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009.BMC Cancer. 2017 Oct 2;17(1):668. doi: 10.1186/s12885-017-3654-1. BMC Cancer. 2017. PMID: 28969625 Free PMC article. No abstract available.
Abstract
Background: Fever and neutropenia (FN) is a common complication of pediatric cancer treatment, but hospital utilization patterns for this condition are not well described.
Methods: Data were analyzed from the Kids' Inpatient Database (KID), an all-payer US hospital database, for 2009. Pediatric FN patients were identified using: age ≤19 years, urgent or emergent admit type, non-transferred, and a combination of ICD-9-CM codes for fever and neutropenia. Sampling weights were used to permit national inferences.
Results: Pediatric cancer patients accounted for 1.5 % of pediatric hospital discharges in 2009 (n = 110,967), with 10.1 % of cancer-related discharges meeting FN criteria (n = 11,261). Two-fifths of FN discharges had a "short length of stay" (SLOS) of ≤3 days, which accounted for approximately $65.5 million in hospital charges. Upper respiratory infection (6.0 %) and acute otitis media (AOM) (3.7 %) were the most common infections associated with SLOS. Factors significantly associated with SLOS included living in the Midwest region (OR = 1.65, 1.22-2.24) or West region (OR 1.54, 1.11-2.14) versus Northeast, having a diagnosis of AOM (OR = 1.39, 1.03-1.87) or viral infection (OR = 1.63, 1.18-2.25) versus those without those comorbidities, and having a soft tissue sarcoma (OR = 1.47, 1.05-2.04), Hodgkin lymphoma (OR = 2.33, 1.62-3.35), or an ovarian/testicular tumor (OR = 1.76, 1.05-2.95) compared with patients without these diagnoses.
Conclusion: FN represents a common precipitant for hospitalizations among pediatric cancer patients. SLOS admissions are rarely associated with serious infections, but contribute substantially to the burden of hospitalization for pediatric FN.
Figures
Similar articles
-
Fever and neutropenia hospital discharges in children with cancer: A 2012 update.Pediatr Hematol Oncol. 2016 Feb;33(1):39-48. doi: 10.3109/08880018.2015.1102998. Epub 2016 Feb 22. Pediatr Hematol Oncol. 2016. PMID: 26900730
-
National Trends in Hospitalization for Fever and Neutropenia in Children with Cancer, 2007-2014.J Pediatr. 2018 Nov;202:231-237.e3. doi: 10.1016/j.jpeds.2018.06.056. Epub 2018 Jul 17. J Pediatr. 2018. PMID: 30029861
-
Cost of Cancer-Related Neutropenia or Fever Hospitalizations, United States, 2012.J Oncol Pract. 2017 Jun;13(6):e552-e561. doi: 10.1200/JOP.2016.019588. Epub 2017 Apr 24. J Oncol Pract. 2017. PMID: 28437150 Free PMC article.
-
Etiology and clinical course of febrile neutropenia in children with cancer.J Pediatr Hematol Oncol. 2009 Sep;31(9):623-9. doi: 10.1097/MPH.0b013e3181b1edc6. J Pediatr Hematol Oncol. 2009. PMID: 19644403 Free PMC article.
-
Does age play a role in fever and neutropenia events and complications: A comparison of adolescents versus younger children with cancer at a tertiary care pediatric hospital, a pilot project.Cancer Rep (Hoboken). 2023 Apr;6(4):e1767. doi: 10.1002/cnr2.1767. Epub 2022 Dec 9. Cancer Rep (Hoboken). 2023. PMID: 36494902 Free PMC article. Review.
Cited by
-
Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?Oncologist. 2022 Aug 5;27(8):625-636. doi: 10.1093/oncolo/oyac074. Oncologist. 2022. PMID: 35552754 Free PMC article. Review.
-
Survey of practices for the clinical management of febrile neutropenia in children in hematology-oncology units in Latin America.Support Care Cancer. 2021 Dec;29(12):7903-7911. doi: 10.1007/s00520-021-06381-9. Epub 2021 Jun 30. Support Care Cancer. 2021. PMID: 34189607 Free PMC article.
-
Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia.Pediatr Blood Cancer. 2020 Nov;67(11):e28570. doi: 10.1002/pbc.28570. Epub 2020 Sep 2. Pediatr Blood Cancer. 2020. PMID: 32881268 Free PMC article.
-
Estimation of Total Costs in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Receiving Tisagenlecleucel from a U.S. Hospital's Perspective.J Manag Care Spec Pharm. 2020 Aug;26(8):971-980. doi: 10.18553/jmcp.2020.20052. Epub 2020 Jun 11. J Manag Care Spec Pharm. 2020. PMID: 32525730 Free PMC article.
-
Predicting in-hospital mortality of patients with febrile neutropenia using machine learning models.Int J Med Inform. 2020 Jul;139:104140. doi: 10.1016/j.ijmedinf.2020.104140. Epub 2020 Apr 15. Int J Med Inform. 2020. PMID: 32325370 Free PMC article.
References
-
- Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Infectious diseases society of America: clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52(4):e56–93. doi: 10.1093/cid/cir073. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
